ARCEDI Biotech Developing Cystic Fibrosis, Cancer Tests; Plans to Expand NIPT Offering
The Danish rare cell diagnostics company is also in the process of migrating its tests from array comparative hybridization to next-generation sequencing.
Source: genomeweb.com